Mania, psychosis, and antipsychotics

Journal of Clinical Psychiatry

Volumn 57, Issue SUPPL. 3, 1996, Pages 14-26

  McElroy, Susan L ^a   Keck Jr , Paul E ^a   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CHLORPROMAZINE; CLOZAPINE; FLUPENTIXOL DECANOATE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; SERTINDOLE; VALPROIC ACID; ZIPRASIDONE;

CLINICAL TRIAL; CONFERENCE PAPER; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MAINTENANCE THERAPY; MANIA; MANIC DEPRESSIVE PSYCHOSIS; ONSET AGE; PRIORITY JOURNAL; PROGNOSIS; PSYCHOSIS; RISK FACTOR; SYMPTOMATOLOGY; TARDIVE DYSKINESIA;

ADOLESCENT; ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLOZAPINE; HUMANS; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; RISPERIDONE; SEVERITY OF ILLNESS INDEX;

EID: 0029973065     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (168)

1. Kraepelin E; Diefendorf AR, trans. Clinical Psychiatry: A Textbook for Students and Physicians. New York, NY: Macmillan Publishing; 1907
2. Kraepelin E; Barclay RM, trans; Robertson GM, ed. Manic-Depressive Insanity and Paranoia. Birmingham, Ala: The Classics of Medicine Library; 1989
3. Rennie TAC, Fowler JB. Prognosis in manic-depressive psychoses. Am J Psychiatry 1942;98:801-814
4. Campbell JD. Manic-Depressive Disease: Clinical and Psychiatric Significance. Philadelphia, Pa: Lippincott; 1953
5. Henderson D, Gillespie RD. A Text-Book of Psychiatry for Students and Practitioners, 8th ed. London, England: Oxford University Press; 1956
6. Astrup C, Fossum A, Holmboe R. A follow-up study of 270 patients with acute affective psychoses. Acta Psychiatr Neurol Scand 1959;34(135, suppl): 11-65
7. Clayton P, Pitts FN Jr, Winokur G. Affective disorder, IV: mania. Compr Psychiatry 1965;6:313-322
8. Winokur G, Clayton PJ, Reich T. Manic Depressive Illness. St. Louis, Mo: Mosby; 1969
9. Carlson GA, Goodwin FK. The stages of mania: a longitudinal analysis of the manic episode. Arch Gen Psychiatry 1973;28:221-228
10. Taylor MA, Abrams R. The phenomenology of mania: a new look at some old patients. Arch Gen Psychiatry 1973;29:520-522
11. Abrams R, Taylor MA. Mania and schizoaffective disorder, manic type: a comparison. Am J Psychiatry 1976;133:1445-1447
12. Leff JP, Fischer M, Bertelsen AL. A cross-national epidemiological study of mania. Br J Psychiatry 1976;129:428-437
13. Taylor MA, Abrams R. Catatonia: prevalence and importance in the manic phase of manic-depressive illness. Arch Gen Psychiatry 1977;34: 1223-1225
14. Pope HG Jr, Lipinski JF. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of schizophrenic symptoms in the light of current research. Arch Gen Psychiatry 1978;35:811-828
15. Akiskal HS, Puzantian VR. Psychotic forms of depression and mania. Psychiatr Clin North Am 1979;2:419-439
16. Carlson G, Strober M. Affective disorders in adolescence. Psychiatr Clin North Am 1979;2:511-526
17. Rosenthal NE, Rosenthal LN, Stallone F, et al. Psychosis as a predictor of response to lithium maintenance treatment in bipolar affective disorder. J Affect Disord 1979;1:237-245
18. Brockington IF, Wainwrighl S, Kendell RE. Manic patients with schizophrenic or paranoid symptoms. Psychol Med 1980;10:73-83
19. Rosenthal NE, Rosenthal LN, Stallone F, et al. Toward the validation of RDC schizoaffective disorder. Arch Gen Psychiatry 1980;37:804-810
20. Abrams R, Taylor MA. Importance of schizophrenic symptoms in the diagnosis of mania. Am J Psychiatry 1981;138:658-661
21. Winokur G. Psychosis in bipolar and unipolar affective illness with special reference to schizoaffective disorder. Br J Psychiatry 1984;145:236-242
22. Black DW, Nasrallah A. Hallucinations and delusions in 1715 patients with unipolar and bipolar affective disorders. Psychopathology 1989;22:28-34
23. Goodwin FK, Jamison KR. Manic-Depressive Illness. New York, NY: Oxford University Press; 1990
24. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-1111
25. Kendler KS. Mood-incongruent psychotic affective illness: a historical and empirical review. Arch Gen Psychiatry 1991;48:362-369
26. Tohen M, Tsuang MT, Goodwin DC. Prediction of outcome in mania by mood-congruent or mood-incongruent psychotic features. Am J Psychiatry 1992;149:1580-1584
27. Janicak PG, Davis JM, Preskorn SH, et al. Principles and Practice of Psychopharmacotherapy. Baltimore, Md: Williams & Wilkins; 1993
28. Akiskal HS. Mood disorders: clinical features. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry, vol 1, 6th ed. Baltimore, Md: Williams & Wilkins; 1995;1123-1152
29. Crow TJ. The continuum of psychosis and its implication for the structure of the gene. Br J Psychiatry 1986;149:419-429
30. Crow TJ. The continuum of psychosis and its genetic origins: the sixty-fifth Maudsley lecture. Br J Psychiatry 1990;156:788-797
31. Taylor MA. Are schizophrenia and affective disorder related? a selective literature review. Am J Psychiatry 1992;149:22-32
32. Maziade M, Marc-André R, Martinez M, et al. Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses. Am J Psychiatry 1995;152:1458-1463
33. Cooper B. Epidemiology. In: Wing JK, ed. Schizophrenia: Toward a New Synthesis. New York, NY: Grune & Stratton; 1978
34. Cooper JE, Kendell RE, Gurland BJ, et al. Psychiatric Diagnosis in New York and London: A Comparative Study of Mental Hospital Admissions. Institute of Psychiatry, Maudsley Monographs, No 20. London, England: Oxford University Press; 1972
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
36. Modell JG, Lenox RH, Weiner S. Inpatient clinical trial of lorazepam for the management of manic agitation. J Clin Psychopharmacol 1985;5: 109-113
37. Lenox RH, Modell JG, Weiner S. Acute treatment of manic agitation with lorazepam. Psychosomatics 1986;27:28-31
38. Kane JM. Role of neuroleptics in manic-depressive illness. J Clin Psychiatry 1988;49(11,suppl):12-13
39. Santos AB, Morton WA. Use of benzodiazepines to improve management of manic agitation. Hosp Community Psychiatry 1989;40:1069-1071
40. Sachs GS. Adjuncts and alternatives to lithium therapy for bipolar affective disorder. J Clin Psychiatry 1989;50(12, suppl):31-39
41. Prien RF, Potter WZ. NIMH workshop report on treatment of bipolar disorder. Psychopharmacol Bull 1990;26:409-427
42. Sachs GS, Weilburg JB, Rosenbaum JF. Clonazepam vs neuroleptics as adjuncts to lithium maintenance. Psychopharmacol Bull 1990;16:137-143
43. Gelenberg AJ. Psychoses. In: Gelenberg AJ, Bassuk EL, Schoonover SC, eds. The Practitioner's Guide to Psychoactive Drugs. 3rd ed. New York, NY: Plenum; 1991:125-178
44. Lenox RH, Newhouse PA, Creelman WL, et al. Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study. J Clin Psychiatry 1992;53:47-52
45. Gerner RH, Stanton A. Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine? J Clin Psychopharmacol 1992;12(1,suppl):57-63
46. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder. Am J Psychiatry 1994;151(12, suppl):1-36
47. Bowden CB. Treatment of bipolar disorder. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995:603-614
48. Post RM. Mood disorders: somatic treatment. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry, vol 1, 6th ed. Baltimore, Md: Williams & Wilkins; 1995:1152-1177
49. Bleuler E; Zinkin J, trans. Dementia praecox or the group of schizophrenias. New York, NY: International Universities Press; 1950
50. Schneider K; Hamilton MW, trans. Clinical Psychopathology. New York, NY: Grune & Stratton; 1959
51. Mellor CS. First rank symptoms of schizophrenia. Br J Psychiatry 1970; 117:15-23
52. Taylor MA. Schneiderian first-rank symptoms and clinical prognostic features in schizophrenia. Arch Gen Psychiatry 1972;26:64-67
53. Carpenter WT, Strauss JS, Mulch S. Are there pathognomonic symptoms in schizophrenia? an empiric investigation of Schneider's first rank symptoms. Arch Gen Psychiatry 1973;28:847-852
54. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Second Edition. Washington, DC: American Psychiatric Association; 1968
55. Feighner JP, Robins E, Guze SB, et al. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63
56. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria, 3rd ed. New York, NY: Biometric Research, New York State Department of Mental Hygiene; 1978
57. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980
58. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Third Edition, Revised. Washington, DC: American Psychiatric Association; 1987
59. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R, Patient Version (SCID-P). New York, NY; Biometric Research, New York State Psychiatric Institute; 1990
60. Solovay MR, Shenton ME, Holzman PS. Comparative studies of thought disorders, I: mania and schizophrenia. Arch Gen Psychiatry 1987;44:13-20
61. Andreasen NC. Thought, language, and communication disorders, I: clinical assessment, definition of terms, and evaluation of their reliability. Arch Gen Psychiatry 1979;36:1315-1321
62. Breakey WR, Goodell H. Thought disorder in mania and schizophrenia evaluated by Bannister's Grid Test for schizophrenic thought disorder. Br J Psychiatry 1972;120:391-395
63. Andreasen NC, Powers PS. Creativity and psychosis: an examination of conceptual style. Arch Gen Psychiatry 1975;32:70-73
64. Andreasen NC. Thought, language, and communication disorders, II: diagnostic significance. Arch Gen Psychiatry 1979;36:1325-1330
65. Grossman LS, Harrow M, Lazar B, et al. Do thought disorders persist in manic patients? Presented at the 134th annual meeting of the American Psychiatric Association; May 9-15, 1981; New Orleans, La
66. Harrow M, Grossman LS, Silverstein ML, et al. Thought pathology in manic and schizophrenic patients: its occurrence at hospital admission and seven weeks later. Arch Gen Psychiatry 1982;339:665-671
67. Simpson DM, Davis GC. Measuring thought disorder with clinical rating scales in schizophrenic and nonschizophrenic patients. Psychiatry Res 1985;15:313-318
68. Grossman LS, Harrow M, Sands JR. Features associated with thought disorder in manic patients at 2-4 year follow-up. Am J Psychiatry 1986; 143:306-311
69. Harrow M, Grossman LS, Silverstein ML, et al. A longitudinal study of thought disorder in manic patients. Arch Gen Psychiatry 1986;43: 781-785
70. Ragin AB, Oltmanns TF. Communicability and thought disorder in schizophrenics and other diagnostic groups: a follow-up study. Br J Psychiatry 1987;150:494-500
71. Shenton ME, Solovay MR, Holzman P. Comparative studies of thought disorders, II: schizoaffective disorder. Arch Gen Psychiatry 1987;44: 21-30
72. Jampala VC, Taylor MA, Abrams R. The diagnostic implications of formal thought disorder in mania and schizophrenia: a reassessment. Am J Psychiatry 1989;146:459-463
73. Wilcox JA. The predictive value of thought disorder in manic psychosis. Psychopathology 1992;25:161-165
74. Bell L. On a form of disease resembling some advanced stages of mania and fever, but so contradistinguished from any ordinarily observed or described combination of symptoms as to render it probable that it may be overlooked and hitherto unrecorded malady. American Journal of Insanity 1849;6:97-127
75. Bond TO. Recognition of acute delirious mania. Arch Gen Psychiatry 1980;37:553-554
76. Hawkins JM, Archer KJ, Strakowski SM, et al. Somatic treatment of catatonia. International Journal of Psychiatry in Medicine 1995;25:350-359
77. Kahlbaum KL; Levi Y, Pridon T, trans. Catatonia. Baltimore, Md: Johns Hopkins University Press; 1973
78. Abrams R, Taylor MA. Catatonia: a prospective clinical study. Arch Gen Psychiatry 1976;33:579-581
79. Strakowski SM, Keck PE, McElroy SL, et al. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry 1995;6: 1-8
80. Young RC, Biggs JT, Siegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435
81. Fichtner CG, Grossman LS, Harrow M, et al. Cyclothymic mood swings in the course of affective disorders and schizophrenia. Am J Psychiatry 1989;146:1149-1154
82. Rosen LN, Rosenthal NE, Van Dusen PH, et al. Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. Am J Psychiatry 1983;140:1523-1524
83. McGlashan TH. Adolescent versus adult onset of mania. Am J Psychiatry 1988;145:221-223
84. Coryell W, Norten SG. Mania during adolescence. J Nerv Ment Dis 1980; 168:611-613
85. Ballenger JC, Reus VI, Post RM. The atypical clinical picture of adolescent mania. Am J Psychiatry 1982;139:602-606
86. Anthony J, Scott P. Manic-depressive psychosis in childhood. Child Psychol Psychiatry 1960;1:53-72
87. Carlson GA, Strober M. Manic-depressive illness in early adolescence: a study of clinical and diagnostic characteristics in six cases. J Am Acad Child Psychiatry 1978;17:138-153
88. Coll PG, Bland R. Manic-depressive illness in adolescence and childhood: review and case report. Can J Psychiatry 1979;24:255-263
89. Hassanyeh F, Davison K. Bipolar affective psychosis with onset before age 16 years: a report of 10 cases. Br J Psychiatry 1980;137: 530-539
90. Rosen LN, Rosenthal NE, Dunner DL, et al. Social outcome compared in psychotic and nonpsychotic bipolar I patients. J Nerv Ment Dis 1983; 171:272-275
91. Lundquist G. Prognosis and course in manic-depressive psychoses: a follow-up study of 319 first admissions. Acta Psychiatrica et Neurologica 1945;(35, suppl):1-96
92. Harrow M, Goldberg JF, Grossman LS, et al. Outcome in manic disorders: a naturalistic follow-up study. Arch Gen Psychiatry 1990;47:665-671
93. Coryell W, Keller M, Lavori P, et al. Affective syndromes, psychotic features, and prognosis, II: mania. Arch Gen Psychiatry 1990;47:658-664
94. Pope HG Jr, Lipinski JF, Cohen BM, et al. Schizoaffective disorder: an invalid diagnosis? a comparison of schizoaffective disorder, schizophrenia, and affective disorder. Am J Psychiatry 1980;137:921-927
95. Williams PV, McGlashan TM. Schizoaffective psychosis, I: comparative long-term outcome. Arch Gen Psychiatry 1987;44:130-137
96. Keck PE Jr, McElroy SL, Strakowski SM, et al. Pharmacologic treatment of schizoaffective disorder. Psychopharmacology (Berl) 1994;114:529-538
97. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
98. Gelenberg AJ. Neuroleptics for bipolar maintenance. Biological Therapies in Psychiatry 1994;17:46-47
99. Johnston G, Gershon S, Burdock EI, et al. Controlled evaluation of lithium and chlorpromazine in the treatment of manic states: an interim report. Compr Psychiatry 1968;9:563-573
100. Platman SR. A comparison of lithium carbonate and chlorpromazine in mania. Am J Psychiatry 1970;127:351-353
101. Spring G, Schweid D, Gray C, et al. A double-blind comparison of lithium and chlorpromazine in the treatment of manic states. Am J Psychiatry 1970;126:1306-1310
102. Johnson G, Gershon S, Burdock EI, et al. Comparative effects of lithium and chlorpromazine in the treatment of acute manic states. Br J Psychiatry 1971;119:267-276
103. Prien RF, Caffey EM, Kleh CJ. Comparison of lithium carbonate and chlorpromazine in the treatment of mania: report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group. Arch Gen Psychiatry 1972;26:146-153
104. Shopsin B, Gershon S, Thompson H, et al. Psychoactive drugs in mania: a controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry 1975;32:34-42
105. Takahashi R, Sakuma A, Itoh K, et al. Comparison of efficacy of lithium carbonate and chlorpromazine in mania: report of collaborative study group on treatment of mania in Japan. Arch Gen Psychiatry 1975;32:1310-1318
106. Goodwin FK, Zis AP. Lithium in the treatment of mania: comparisons with neuroleptics. Arch Gen Psychiatry 1979;36:840-844
107. Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980;2:279-288
108. Naylor GJ, Scott CR. Depot injections for affective disorders [letter]. Br J Psychiatry 1980;136:105
109. Ahlfors UG, Baastrup PC, Dencker SJ, et al. Flupenthixol decanoate in recurrent manic-depressive illness: a comparison with lithium. Acta Psychiatr Scand 1981;64:226-237
110. Lowe MR, Batchelor DH. Depot neuroleptics and manic depressive psychosis. Int Clin Psychopharmacol 1986;1(suppl 1):53-62
111. Esparon J, Kolloori J, Naylor GJ. Comparison of the prophylactic action of flupenthixol with placebo in lithium treated manic-depressive patients. Br J Psychiatry 1986;148:723-725
112. Lowe MR, Batchelor DH. Lithium and neuroleptics in the management of manic depressive psychosis. Human Psychopharmacology 1990;5:267-274
113. White E, Cheung P, Silverstone T. Depot antipsychotics in bipolar affective disorder. Int Clin Psychopharmacol 1993;8:119-122
114. Janicak PG, Newman RH, Davis JM. Advances in the treatment of manic and related disorders: a reappraisal. Psychiatric Annals 1992;22:92-103
115. Ballenger JC, Post RM. Therapeutic effects of carbamazepine in affective illness: a preliminary report. Community Psychopharmacol 1978;2: 159-175
116. Pope HG Jr, McElroy SL, Keck PE Jr, et al. Valproate in the treatment of acute mania. Arch Gen Psychiatry 1991;48:62-68
117. Bowden CL, Brugger AM, Swann AC, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. JAMA 1994;271:918-924
118. Morgan HG. The incidence of depressive symptoms during recovery from hypomania. Br J Psychiatry 1972;120:537-539
119. Kukopulos A, Reginaldi D, Laddomada P, et al. Course of the manic-depressive cycle and changes caused by treatments. Pharmakopsychiatrie Neuropsychopharmakologie 1980;13:156-167
120. Levine S. The management of resistant depression. Acta Psychiatr Belg 1986;86:141-151
121. Kane JM, Smith JM. Tardive dyskinesia: prevalence and risk factors. Arch Gen Psychiatry 1982;39:473-481
122. Mukherjee S, Rosen AM, Caracci G, et al. Persistent tardive dyskinesia in bipolar patients. Arch Gen Psychiatry 1986;43:342-346
123. Nasrallah HA, Churchill CM, Hamdan-Allan GA. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 1988;145:1455-1456
124. Kane JM, Jeste DV, Barnes IRE, et al. Tardive Dyskinesia: A Task Force Report of the American Psychiatric Association. Washington, DC: American Psychiatric Association; 1992
125. Addonizio G. Rapid induction of extrapyramidal side effects with combined use of lithium and neuroleptics. J Clin Psychopharmacol 1985; 5:296-298
126. Lyskowski J, Nasrallah HA, Dunner FJ, et al. A longitudinal survey of side effects in a lithium clinic. J Clin Psychiatry 1982;43:284-286
127. Keck PE Jr, Pope HG Jr, Cohen BM, et al. Risk factors for neuroleptic malignant syndrome: a case-control study. Arch Gen Psychiatry 1989; 46:914-918
128. Keck PE Jr, McElroy SL, Tugrul KC, et al. Valproate oral loading in the treatment of acute mania. J Clin Psychiatry 1993;54:305-308
129. McElroy SL, Keck PE Jr, Tugrul KC, et al. Valproate as a loading treatment in acute mania. Neuropsychobiology 1993;27:146-149
130. McElroy SL, Keck PE Jr. Antiepileptic drugs. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995: 351-375
131. Kane J, Honingfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-796
132. Baldessarini RJ, Frankenburg FR. Clozapine: a novel antipsychotic agent. N Engl J Med 1991;324:746-754
133. Casey DE. What makes a neuroleptic atypical? In: Meltzer HE, ed. Novel Antipsychotic Drugs. New York, NY: Raven Press; 1992:241-251
134. Ereshefsky L, Lacombe S. Pharmacological profile of risperidone. Can J Psychiatry 1993;38(3, suppl):80-88
135. Leysen JE, Janssen PMF, Megens AAHP, et al. Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. J Clin Psychiatry 1994;55(2, suppl):5-12
136. Meltzer HE. An overview of the mechanism of action of clozapine. J Clin Psychiatry 1994;55(suppl B):47-52
137. Richelson E. Preclinical pharmacology of antipsychotic drugs: relationship to efficacy and side effects. J Clin Psychiatry Monograph 1994; 12:17-23
138. Owens MJ, Risch SC. Atypical antipsychotics. In: Schatzberg AF, Nemeroff CB, eds. The American Psychiatric Press Textbook of Psychopharmacology. Washington, DC: American Psychiatric Press; 1995: 263-280
139. Mendelowitz AJ, Lieberman JA. New findings in the use of atypical antipsychotic drugs, I: focus on risperidone. J Clin Psychiatry Case and Comment Series 1995;2(1):1-56
140. Lindström LH. A retrospective study of the long-term efficacy and safety of clozapine in 96 schizophrenic and schizoaffective patients during a 13-year period. Psychopharmacology (Berl) 1989;99(suppl):84-86
141. Naber D, Hippius H. The European experience with use of clozapine. Hosp Community Psychiatry 1990;41:886-890
142. Stefanoqicz P. Initial results of clozapine and lithium carbonate treatment of manic syndromes in the course of schizoaffective psychosis. Psychiatr Pol 1990;24:27-30
143. Calabrese JR, Meltzer HE, Markovitz PJ. Clozapine prophylaxis in rapid cycling bipolar disorder [letter]. J Clin Psychopharmacol 1991;11: 396-397
144. McElroy SL, Dessain EC, Pope HG Jr, et al. Clozapine in the treatment of psychotic mood disorders, schizoaffective disorder, and schizophrenia. J Clin Psychiatry 1991;52:411-414
145. Suppes T, McElroy SL, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
146. Frankenburg FT. Clozapine and bipolar disorder. J Clin Psychopharmacol 1993;13:289-290
147. Cole JO, Banov MD, Green A, et al. Clozapine in the treatment of refractory acute bipolar mania. In: New Research Program and Abstracts of the 146th annual meeting of the American Psychiatric Association; May 26, 1993; San Francisco, Calif. Abstract NR455:174
148. Malhotra A, Litman RE, Se TP, el al. Clozapine response in schizoaffective disorder. In: New Research Program and Abstracts of the 146th annual meeting of the American Psychiatric Association; May 26, 1993; San Francisco, Calif. NR53:73
149. Banov MD, Zarate CA Jr, Tohen M, et al. Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 1994;55:295-300
150. Kimmel SE, Calabrese JR, Woyshville MJ, et al. Clozapine in treatment-refractory mood disorders. J Clin Psychiatry 1994;55(9, suppl B):91-93
151. Suppes T, Phillips KA, Judd CR. Clozapine treatment of non-psychotic rapid cycling bipolar disorder: a report of three cases. Biol Psychiatry 1994;36:338-340
152. Zarate CA Jr, Tohen M, Banov MD, et al. Is clozapine a mood stabilizer? J Clin Psychiatry 1995;56:108-112
153. Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995;56:411-417
154. Parsa MA, Ramirez LF, Loula EC, et al. Effect of clozapine on psychotic depression and parkinsonism. J Clin Psychopharmacol 1991;11:330-331
155. Rickels K, Schweizer E, Clary C, et al. Nefazodone and imipramine in major depression: a placebo-controlled trial. Br J Psychiatry 1994;164:802-805
156. Singh AN, Catalan J. Risperidone in HIV-related manic psychosis. Lancet 1994;344:1029-1030
157. Goodnick PJ. Risperidone treatment of refractory acute mania [letter]. J Clin Psychiatry 1995;56:431-432
158. Ghaemi SN, Sachs GS, Baldassano CF, et al. Management of bipolar disorder with adjunctive risperidone: response to open treatment. In: New Research Program and Abstracts of the 148th annual meeting of the American Psychiatric Association; May 22, 1995; Miami, Fla. Abstract NR82:77
159. Tohen M, Zarate CA Jr, Centorrino F, et al. Risperidone in the treatment of mania. In: New Research Program and Abstracts of the 148th annual meeting of the American Psychiatric Association; May 22, 1995; Miami, Fla. Abstract NR286:132
160. Keck PE Jr, Wilson DR, Strakowski SM, et al. Clinical predictors of acute risperidone response in schizophrenia, schizoaffective disorder, and psychotic mood disorders. J Clin Psychiatry 1995;56:466-470
161. Jacobsen FM. Risperidone in the treatment of affective illness and obssessive-compulsive disorder. J Clin Psychiatry 1995;56:423-429
162. Dwight MM, Keck PE Jr, Stanton SP, et al. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:554-555
163. Sajatovic M. A pilot study evaluating the efficacy of risperidone in treatment-refractory, acute bipolar and schizoaffective mania. Presented at the 35th annual meeting of the New Clinical Drug Evaluation Unit; May 31-June 3, 1995; Orlando, Fla. Abstract 19
164. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812
165. Byerly MJ, Greer RA, Evans DL. Behavioral stimulation associated with risperidone initiation [letter]. Am J Psychiatry 1995;152:1096-1097
166. Chouinard G, Jones B, Remington G, et al. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenia. J Clin Psychopharmacol 1993;13: 25-40
167. Hillert A, Maier W, Wetzel H, et al. Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome: a functional approach. Pharmacopsychiatry 1992;25:213-217
168. Beasly C, Tran P, Tamura G. Olanzapine versus haloperidol: results of the multi-center international trial. Presented at the American College of Neuropsychiatry; December 15, 1995; San Juan, Puerto Rico